Deep dive: Biopharma layoffs in Q1
Listen now
Description
This week on "The Top Line," we explore biopharma layoffs in the first quarter of 2024.
Using data from Fierce Biotech's layoff tracker, Gabrielle Masson and Max Bayer analyze the trends of layoffs in the first quarter of 2024, comparing them to previous years. With a notable number of layoff rounds marking the start of the year, they examine the factors behind this ongoing challenge while also highlighting positive industry developments.
To learn more about the topics in this episode:
No reprieve for biopharma layoffs in Q1: Fierce Biotech analysis
Fierce Biotech Layoff Tracker 2024
See omnystudio.com/listener for privacy information.
More Episodes
The Fierce Biotech team published a four-part series this week exploring cell therapy, a modality that has faced clinical challenges, manufacturing constraints and multiple practice-changing events.
In today’s episode, Fierce’s Annalee Armstrong and Gabrielle Masson discuss the series of...
Published 05/31/24
Published 05/31/24
This week’s episode of “The Top Line,” is the final part of a three-part series diving into the latest advancements in cell and gene therapy manufacturing.
In this episode, Fierce Pharma’s Fraiser Kansteiner is joined by Bruce Levine, Ph.D., who is the co-inventor of Kymriah and the Barbara and...
Published 05/24/24
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
